Home / Diabetes In Control (page 422)

Diabetes In Control

Letter from the Editor #671

Our newly diagnosed patients receive so much information from friends, family, and the internet that they become desensitized to having diabetes and what that means in real terms. This overload of information and long list of do’s and don’ts can be blamed for many patients just giving up before they …

Read More »

Glycemic Triad Patient Education Tool

Glycomark

Glycemic Triad Patient Education Tool When managing various glycemic markers, explaining what the numbers mean can be a challenge.  This tool explains the ADA goals for A1C, Fasting Glucose and Postmeal Glucose.  It also introduces an FDA-cleared glycemic marker called 1,5-anhydroglucitol (1,5-AG; GlycoMark®) and provides a 3-day meal and glucose log …

Read More »

Editor’s Note, DCMS #130

About three quarters of our diabetes patients have dyslipidemia and elevated triglycerides, along with high insulin resistance and an increased risk of CAD. Our Clinical Text from Joslin looks at this problem and also answers the question of whether improving glucose control can impact lipid control. Many of the dyslipidemic …

Read More »

Joslin’s Diabetes Deskbook, Updated 2nd Edition, Excerpt #30: Macrovascular Complications, Part 2

Joslin_Diabetes_Deskbook

Richard S. Beaser, MD Michael Johnstone, MD The week’s excerpt answers the following questions:  What is the relationship between triglyceride levels and the degree of insulin resistance? Which lipid abnormalities are markers of coronary artery disease (CAD)? What are the current goals for lipids for diabetic patients? Can improved glucose …

Read More »

Letter from the Editor #670

Last November our intern Andre McMahon put together a good article on How the Liver Affects Insulin and Vice Versa: Part 1 Carbohydrate Metabolism with his insights into carbohydrate metabolism. This week he has Part 2, How Obesity and Lipid Metabolism play into how the Liver Affects Insulin and Vice Versa. …

Read More »